Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pembrolizumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pembrolizumabmarket, defines the market attractiveness level of Pembrolizumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pembrolizumab industry, describes the types of Pembrolizumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pembrolizumab market and the development prospects and opportunities of Pembrolizumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pembrolizumab market in Chapter 13.
By Player:
Merck
By Type:
50mg Injection
100mg Injection
By End-User:
Advanced Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Unresectable or Metastatic Solid Tumor
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pembrolizumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pembrolizumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pembrolizumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pembrolizumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pembrolizumab Market Analysis and Outlook to 2022
-
7.1 Global Pembrolizumab Consumption (2017-2022)
-
7.2 United States Pembrolizumab Consumption (2017-2022)
-
7.3 Europe Pembrolizumab Consumption (2017-2022)
-
7.4 China Pembrolizumab Consumption (2017-2022)
-
7.5 Japan Pembrolizumab Consumption (2017-2022)
-
7.6 India Pembrolizumab Consumption (2017-2022)
-
7.7 South Korea Pembrolizumab Consumption (2017-2022)
8 Region and Country-wise Pembrolizumab Market Analysis and Outlook to 2028
-
8.1 Global Pembrolizumab Consumption Forecast (2022-2028)
-
8.2 United States Pembrolizumab Consumption Forecast (2022-2028)
-
8.3 Europe Pembrolizumab Consumption Forecast (2022-2028)
-
8.4 China Pembrolizumab Consumption Forecast (2022-2028)
-
8.5 Japan Pembrolizumab Consumption Forecast (2022-2028)
-
8.6 India Pembrolizumab Consumption Forecast (2022-2028)
-
8.7 South Korea Pembrolizumab Consumption Forecast (2022-2028)
9 Global Pembrolizumab Market Outlook by Types and Applications to 2022
-
9.1 Global Pembrolizumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 50mg Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 100mg Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Pembrolizumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Advanced Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Head and Neck Squamous Cell Carcinoma (HNSCC) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Unresectable or Metastatic Solid Tumor Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Pembrolizumab Market Outlook by Types and Applications to 2028
-
10.1 Global Pembrolizumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 50mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 100mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pembrolizumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Advanced Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Head and Neck Squamous Cell Carcinoma (HNSCC) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Unresectable or Metastatic Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Pembrolizumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pembrolizumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pembrolizumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pembrolizumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pembrolizumab Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Pembrolizumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Pembrolizumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pembrolizumab
-
Figure Pembrolizumab Picture
-
Table Global Pembrolizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pembrolizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pembrolizumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pembrolizumab Consumption by Country (2017-2022)
-
Figure United States Pembrolizumab Consumption and Growth Rate (2017-2022)
-
Table Europe Pembrolizumab Consumption and Growth Rate (2017-2022)
-
Figure China Pembrolizumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Pembrolizumab Consumption and Growth Rate (2017-2022)
-
Figure India Pembrolizumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pembrolizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Pembrolizumab Consumption Forecast by Country (2022-2028)
-
Figure United States Pembrolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pembrolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pembrolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pembrolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pembrolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pembrolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 50mg Injection Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Advanced Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Head and Neck Squamous Cell Carcinoma (HNSCC) Consumption and Growth Rate (2017-2022)
-
Figure Global Unresectable or Metastatic Solid Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 50mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Advanced Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head and Neck Squamous Cell Carcinoma (HNSCC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Unresectable or Metastatic Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pembrolizumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pembrolizumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Pembrolizumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Pembrolizumab Product and Service
-
